OEMs, suppliers and surgeons confirm that the spine industry remains fixated on procedure enhancement through surgical assistance technologies and device design via coatings, materials and manufacturing.
Corin targeted GOT as part of its plan for global expansion in the joint reconstruction market.
GOT has an Australian footprint and an export business in the USA.
After twenty years at the helm, founder Dr. Alberto Siccardi will transition CEO duties to his son, Francesco Siccardi, currently Executive Vice President of Medacta International.
You must demonstrate to
FDA that you are in control of the situation and are attempting to comply voluntarily by doing everything possible to ensure Agency specifications are met.
Two completed study announcements include Bone Therapeutics' ALLOB® allogenic bone cell therapy to treat fractures and Histogenics' NeoCart® to treat knee cartilage defects.
A solid strategy and subsequent execution can maximize the opportunity to achieve a specific regulatory goal, such as to obtain approval or clearance of a new orthopaedic product.
